Glaucoma UK has announced the appointments of the new President and President-elect for the UK and Éire Glaucoma Society (UKEGS). Taking over from Ms Nishani Amerasinghe, the 2025 President is Dr Andrew Tatham who is a consultant at Princess Alexandra...
Worldwide prevalence of myopia has increased rapidly in recent years and has now reached epidemic levels, particularly in South-East Asia where prevalence is around 80% [1-4]. Myopia prevalence is also increasing in the United States and Europe where it is...
This provider-led peer review will focus on navigating post-operative complications in cataract surgery. While the risk of complications is low, understanding how to assess, diagnose, and manage them is essential for optometrists involved in post-operative care. This session will provide...
Modern cataract surgery aims to provide patients with the best possible visual outcome with the least dependence on spectacles and minimal or no complications and to treat both cataract and refractive errors with a single procedure. Phacoemulsification is the standard...
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...
The early 1980s were a glorious time to be a teenager. Along with BMX bikes, Airwolf and Quattro, we had a plethora of new music genres to be enthralled by. The band Frankie Goes to Hollywood with their dance /...
TED seriesNational meeting series on thyroid eye diseaseThe Adnexal Team at Moorfields Eye Hospital are pleased to present TED series, an ongoing series of FREE, evening hybrid meetings covering key aspects of thyroid eye disease. The aim of the meetings...
It is well known that multifocal intraocular lenses (IOLs) can generate more than one focus to restore distance and near vision, but patients may experience adverse optical phenomena such as decreased contrast sensitivity and induced glare or halos. The authors...
This article discusses the use of topical and systemic therapy in the management of advanced periocular tumours. It focuses on those that have gained United States Food and Drug Administration approval; namely imiquimod, vismodegib, sonidegib, pembrolizumab and cemiplimab. Imiquimod is...